Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

112.66
Delayed Data
As of Dec 07
 -4.73 / -4.03%
Today’s Change
93.05
Today|||52-Week Range
127.00
-5.93%
Year-to-Date
Trump Warns Investors "I'm Going To Bring Down Drug Prices"
Dec 07 / MotleyFool.com - Paid Partner Content
3 Top Healthcare Stocks
Dec 06 / MotleyFool.com - Paid Partner Content
Why You Should Let Celgene Corporation Invest Your Money
Dec 07 / MotleyFool.com - Paid Partner Content
Acceleron, Celgene Present Myelodysplastic Syndromes Data
Dec 05 / Zacks.com - Paid Partner Content
Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally
Dec 07 / TheStreet.com - Paid Partner Content
Why Celgene Shares Jumped 13.9% In November
Dec 05 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus
Dec 07 / Zacks.com - Paid Partner Content
Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment
Dec 04 / TheStreet.com - Paid Partner Content
Juno Reports Positive Phase I Study Data on Lymphoma Drug
Dec 06 / Zacks.com - Paid Partner Content
Why bluebird bio Shares Rallied 24.7% In November
Dec 03 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close117.39
Today’s open114.88
Day’s range110.05 - 114.91
Volume10,177,928
Average volume (3 months)4,481,478
Market cap$91.0B
Dividend yield--
Data as of 12/07/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+25.60%
Earnings growth (next 5 years)+21.20%
Revenue growth (last year)+16.47%
P/E ratio42.8
Price/Sales11.10
Price/Book15.60

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.14-0.37%
BMYBristol-Myers Squibb-0.79-1.41%
ABBVAbbVie-1.63-2.65%
SNYSanofi-0.14-0.34%
Data as of 12/07/2016

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$1.59
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts


Search for Jobs